| |
| |
|
| Insider
Information: |
Hassan Fred |
| Relationship: |
Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
2,176,602 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,607,289 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,176,602 |
|
|
| Total
Value |
$7,607,289 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -18.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Chairman and CEO, Dire... |
2009-11-03 |
0 |
2003-11-26 |
0 |
Premium* |
|
|
Avon Products Inc |
AVP |
Director |
2011-02-25 |
49,079 |
2004-05-06 |
0 |
Premium* |
|
|
Time Warner Inc |
TWX |
|
2018-06-14 |
0 |
2010-03-03 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2013-08-29 |
53,969 |
2013-08-22 |
0 |
Premium* |
|
|
Amgen Inc |
AMGN |
Director |
2020-05-05 |
9,191 |
2015-08-04 |
0 |
Premium* |
|
|
Precigen Inc |
PGEN |
Director |
2024-03-14 |
1,029,834 |
2016-12-01 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
19,300 |
2021-12-29 |
0 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
Director |
2023-04-20 |
1,015,229 |
|
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Director |
– • – |
2016-12-01 |
4 |
B |
$29.02 |
$200,266 |
D/D |
6,900 |
6,900 |
2.39 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
154,687 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2019-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,911 |
32,358 |
0 |
- |
|
| AVP |
Avon Products Inc |
Director |
– • – |
2010-02-19 |
4 |
OE |
$19.12 |
$152,960 |
D/D |
8,000 |
41,079 |
0 |
- |
|
| AVP |
Avon Products Inc |
Director |
– • – |
2011-02-25 |
4 |
OE |
$21.56 |
$172,480 |
D/D |
8,000 |
49,079 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2019-03-08 |
4 |
A |
$5.06 |
$56,500 |
D/D |
11,166 |
24,447 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,212 |
198,731 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$14.17 |
$273,390 |
D/D |
19,300 |
19,300 |
2.39 |
% |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,703 |
57,061 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2022-02-22 |
4 |
A |
$2.03 |
$56,499 |
D/D |
27,832 |
182,519 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2020-03-13 |
4 |
A |
$2.01 |
$56,499 |
D/D |
28,109 |
85,170 |
0 |
- |
|
| TWX |
Time Warner Inc |
Director |
– • – |
2010-03-03 |
4 |
B |
$29.83 |
$1,014,172 |
D/D |
34,000 |
34,000 |
2.39 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-14 |
4 |
A |
$1.43 |
$62,999 |
D/D |
44,055 |
1,029,834 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2023-03-09 |
4 |
A |
$1.17 |
$56,499 |
D/D |
48,290 |
308,597 |
0 |
- |
|
| TWX |
Time Warner Inc |
|
• • – |
2018-06-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(49,089) |
0 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2013-08-29 |
4 |
B |
$99.01 |
$5,049,459 |
D/D |
51,000 |
53,969 |
2.39 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2023-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,576 |
260,307 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
147,359 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2006-12-01 |
4 |
D |
$21.93 |
$2,032,911 |
D/D |
(92,700) |
610,800 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2008-04-25 |
4 |
D |
$18.64 |
$1,727,928 |
D/D |
(92,700) |
828,100 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2009-04-01 |
4 |
D |
$23.70 |
$2,196,990 |
D/D |
(92,700) |
935,400 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
985,779 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2008-04-24 |
4 |
B |
$18.21 |
$2,008,774 |
D/D |
110,000 |
720,800 |
2.81 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2006-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,000 |
703,500 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chairman and CEO |
• • – |
2008-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,000 |
920,800 |
0 |
- |
|
55 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
